FDA Approved: LIOMNY — Original Application (SIGMAPHARM LABORATORIES, LLC)

View source ↗

Summary

FDA approved LIOMNY (liothyronine sodium) from SigmaPharm Laboratories as an original abbreviated new drug application (ANDA) for the treatment of hypothyroidis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypothyroidism

Drugs mentioned

• LIOMNY (LIOTHYRONINE SODIUM)

Snippet

ORIG AP for LIOMNY (LIOTHYRONINE SODIUM)